Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.4
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Also (top-3)
cancer0.2
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
OMISIRGE® (omidubicel-onlv) | Allogeneic Hematopoietic Progenitor Cell Therapy
Description
Omisirge® (omidubicel-onlv) is the first FDA-approved allogeneic progenitor cell therapy for patients aged 12 and up with hematologic malignancies in need of an allo-HCT.
Final URL
Language
en (html)
Scanned at
2026-06-25 13:29:11